Purchases and Sales Made in Q3 2021 in Synthetic Biologics, Inc. (SYN)
This table provides information about the institutional ownership of Synthetic Biologics, Inc. (SYN) during Q3 2021. The information is specifically focused on institutions that hold shares of Synthetic Biologics, Inc..
Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
---|---|---|---|---|---|---|---|
Nov 12, 2021
Q3 2021
|
Gsa Capital Partners LLP
London, X0 |
BUY
|
- |
275KNew |
$1.18M - $1.6M
|
275K
$165K
|
|
Nov 15, 2021
Q3 2021
|
Two Sigma Investments, LP
New York, NY |
BUY
|
- |
191K+ 878.53% |
$823K - $1.11M
|
213K
$128K
|
|
Nov 15, 2021
Q3 2021
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
BUY
|
- |
94.6K+ 280.71% |
$407K - $549K
|
128K
$77K
|
|
Nov 15, 2021
Q3 2021
|
Ubs Group Ag
|
BUY
|
- |
52.5K+ 88901.69% |
$226K - $304K
|
52.5K
$31.5K
|
|
Nov 15, 2021
Q3 2021
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
33.1K+ 313.0% |
$142K - $192K
|
43.7K
$26.2K
|
|
Nov 12, 2021
Q3 2021
|
Blair William & CO
Chicago, IL |
BUY
|
- |
32.3K+ 18.88% |
$139K - $188K
|
204K
$122K
|
|
Nov 15, 2021
Q3 2021
|
Susquehanna International Group, LLP
Bala Cynwyd, PA |
BUY
|
- |
22KNew |
$94.6K - $128K
|
22K
$13.2K
|
|
Nov 15, 2021
Q3 2021
|
Morgan Stanley
New York, NY |
BUY
|
- |
21.1KNew |
$90.7K - $122K
|
21.1K
$12.7K
|
|
Nov 12, 2021
Q3 2021
|
Geode Capital Management, LLC
Boston, MA |
BUY
|
- |
20K+ 2.1% |
$86.2K - $116K
|
976K
$586K
|
|
Nov 10, 2021
Q3 2021
|
Mercer Global Advisors Inc
Denver, CO |
BUY
|
- |
20KNew |
$86K - $116K
|
20K
$12K
|
|
Nov 15, 2021
Q3 2021
|
Hrt Financial LP
New York, NY |
BUY
|
- |
13.9KNew |
$59.6K - $80.4K
|
13.9K
$8.31K
|
|
Nov 15, 2021
Q3 2021
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
10.6K+ 390.57% |
$45.4K - $61.2K
|
13.3K
$7.96K
|
|
Nov 02, 2021
Q3 2021
|
Clearview Wealth Advisors LLC
|
BUY
|
- |
2.01K+ 10.91% |
$8.64K - $11.7K
|
20.4K
$12.3K
|
|
Nov 15, 2021
Q3 2021
|
Bank Of America Corp
Charlotte, NC |
BUY
|
- |
612+ 505.79% |
$2.63K - $3.55K
|
733
$440
|
|
Nov 15, 2021
Q3 2021
|
Royal Bank Of Canada
Toronto, A6 |
BUY
|
- |
115+ 159.72% |
$495 - $667
|
187
$112
|
|
Oct 06, 2021
Q3 2021
|
Ifp Advisors, Inc
|
BUY
|
- |
50+ 1.32% |
$215 - $290
|
3.83K
$2.3K
|
|
Nov 09, 2021
Q3 2021
|
Barclays PLC
London, X0 |
BUY
|
- |
47New |
$202 - $273
|
47
$28.2
|
|
Nov 09, 2021
Q3 2021
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
Nov 15, 2021
Q3 2021
|
Wells Fargo & Company
San Francisco, CA |
SELL
|
- |
-40- 4.71% |
$172 - $232
|
809
$485
|
|
Nov 02, 2021
Q3 2021
|
Victory Capital Management Inc
|
SELL
|
- |
-990- 4.81% |
$4.26K - $5.74K
|
19.6K
$11.8K
|
|
Nov 12, 2021
Q3 2021
|
Virtu Financial LLC
New York, NY |
SELL
|
- |
-57.6K- 23.03% |
$247K - $334K
|
192K
$115K
|